Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 115 | 125 | +10 |
| Shares | 133.0M | 134.0M | +974.2K (+0.7%) |
| Value | $3.76B | $4.23B | +$467.1M (+12.4%) |
New holders (25)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (15)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Ikarian Capital, LLC | 178,100 | $5.03M |
| Casdin Capital, LLC | 80,000 | $2.26M |
| BNP Paribas Arbitrage, SA | 61,985 | $1.75M |
| Twinbeech Capital LP | 39,072 | $1.10M |
| Boothbay Fund Management, LLC | 33,959 | $960.0K |
| HighVista Strategies LLC | 23,611 | $667.0K |
| Verition Fund Management LLC | 19,457 | $550.0K |
| Camden Capital, LLC | 14,500 | $410.0K |
| Engineers Gate Manager LP | 7,638 | $216.0K |
| Amundi | 7,055 | $210.0K |
| Dark Forest Capital Management LP | 3,070 | $87.0K |
| Point72 Hong Kong Ltd | 1,470 | $42.0K |
| Cutler Group LP | 1,000 | $28.0K |
| High Net Worth Advisory Group LLC | 1,000 | $28.0K |
| Macquarie Group Ltd | 0 | $19.0K |